Thursday, March 17, 2016

GSK CEO Andrew Witty to Retire

GlaxoSmithKline said Andrew Witty would retire as chief executive in March 2017 after roughly 10 years as CEO of the drug maker.

from WSJ.com: US Business http://ift.tt/21wpqCn
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)